PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-9.73%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-8.23%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-44.22%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-44.22%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
56.92%
Positive net income growth while CVE is negative. John Neff might see a big relative performance advantage.
58.82%
Positive EPS growth while CVE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
55.15%
Positive diluted EPS growth while CVE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.30%
Slight or no buybacks while CVE is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.15%
Slight or no buyback while CVE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-3.05%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
32.55%
OCF growth under 50% of CVE's 80.53%. Michael Burry might suspect questionable revenue recognition or rising costs.
79.57%
FCF growth under 50% of CVE's 1306.98%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-14.59%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-14.59%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-14.59%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
24.93%
Positive 10Y CAGR while CVE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
24.93%
Below 50% of CVE's 100.00%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
24.93%
Positive short-term CAGR while CVE is negative. John Neff would see a clear advantage in near-term profit trajectory.
165.80%
Positive growth while CVE is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
165.80%
Positive 5Y equity/share CAGR while CVE is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
165.80%
Positive short-term equity growth while CVE is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.60%
Our AR growth while CVE is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
28.21%
We show growth while CVE is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.22%
Positive asset growth while CVE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
5.43%
Positive BV/share change while CVE is negative. John Neff sees a clear edge over a competitor losing equity.
-7.99%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
315.92%
We expand SG&A while CVE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.